Ibex Investors’s HCA Healthcare HCA Stock Holding History

Ibex Investors’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,531	Closed	-$213K	–	197
2018 Q3	$213K	Buy	+1,531	New	+$191K	0.12%	88

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MAM

Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Ibex Investors's HCA Position: Q4 2018 in Review

Ibex Investors sold out of HCA Healthcare (HCA) in Q4 2018, closing a stake of 1,531 shares — an estimated $213K sold.

Ibex Investors first reported a position in HCA in Q3 2018 and held it in 1 quarter. The position peaked at $213K in Q3 2018. 699 funds tracked by Wall St. Rank hold HCA as of Q4 2018.

Ibex Investors reported no remaining HCA Healthcare position as of Q4 2018 after selling out during the quarter.
Ibex Investors sold 1,531 HCA Healthcare shares in Q4 2018, an estimated $213K.
Ibex Investors first reported a position in HCA Healthcare in Q3 2018 and held it in 1 quarter.
Ibex Investors's HCA Healthcare position peaked at $213K in Q3 2018.
699 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.